- Home
- AUPH vs HDL Comparison
AUPH vs HDL Comparison
Compare AUPH & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- HDL
- Stock Information
- Founded
- AUPH 1993
- HDL 2016
- Country
- AUPH Canada
- HDL Singapore
- Employees
- AUPH N/A
- HDL N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- HDL Restaurants
- Sector
- AUPH Health Care
- HDL Consumer Discretionary
- Exchange
- AUPH Nasdaq
- HDL Nasdaq
- Market Cap
- AUPH 1.1B
- HDL 1.2B
- IPO Year
- AUPH 1999
- HDL 2024
- Fundamental
- Price
- AUPH $7.78
- HDL $19.02
- Analyst Decision
- AUPH Strong Buy
- HDL
- Analyst Count
- AUPH 2
- HDL 0
- Target Price
- AUPH $11.50
- HDL N/A
- AVG Volume (30 Days)
- AUPH 1.6M
- HDL 2.3K
- Earning Date
- AUPH 07-31-2025
- HDL 08-26-2025
- Dividend Yield
- AUPH N/A
- HDL N/A
- EPS Growth
- AUPH N/A
- HDL 110.82
- EPS
- AUPH 0.27
- HDL 0.06
- Revenue
- AUPH $247,295,000.00
- HDL $789,766,000.00
- Revenue This Year
- AUPH $12.15
- HDL $17.95
- Revenue Next Year
- AUPH $18.31
- HDL $13.32
- P/E Ratio
- AUPH $28.55
- HDL $313.57
- Revenue Growth
- AUPH 29.20
- HDL 10.91
- 52 Week Low
- AUPH $5.20
- HDL $13.94
- 52 Week High
- AUPH $10.67
- HDL $30.00
- Technical
- Relative Strength Index (RSI)
- AUPH 46.31
- HDL N/A
- Support Level
- AUPH $7.36
- HDL N/A
- Resistance Level
- AUPH $8.86
- HDL N/A
- Average True Range (ATR)
- AUPH 0.35
- HDL 0.00
- MACD
- AUPH -0.05
- HDL 0.00
- Stochastic Oscillator
- AUPH 31.43
- HDL 0.00
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.